ASMB Earnings Assembly Biosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.54 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.55 | 2026-03-19 | 10-K |
| Q3 2025 | 2025-09-30 | -3.03 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.51 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.17 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -6.69 | 2026-03-19 | 10-K |
| Q3 2025 | 2024-09-30 | -5.12 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -3.64 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.66 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -13.38 | 2025-03-20 | 10-K |
| Q3 2024 | 2023-09-30 | -11.61 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -8.33 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -4.46 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -23.08 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.46 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.99 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.48 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -3.00 | 2023-03-22 | 10-K |
| Q3 2022 | 2021-09-30 | -1.63 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.23 | 2022-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.